Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Total Non-Current Liabilities (2017 - 2025)

Inspire Medical Systems' Total Non-Current Liabilities history spans 9 years, with the latest figure at $126.1 million for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities rose 6.34% year-over-year to $126.1 million; the TTM value through Dec 2025 reached $126.1 million, up 6.34%, while the annual FY2025 figure was $126.1 million, 6.34% up from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $126.1 million at Inspire Medical Systems, down from $141.1 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $141.1 million in Q3 2025 and bottomed at $50.2 million in Q1 2021.
  • The 5-year median for Total Non-Current Liabilities is $89.5 million (2023), against an average of $86.4 million.
  • The largest annual shift saw Total Non-Current Liabilities surged 114.55% in 2021 before it dropped 2.22% in 2022.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $65.9 million in 2021, then rose by 4.28% to $68.7 million in 2022, then surged by 49.81% to $103.0 million in 2023, then increased by 15.14% to $118.5 million in 2024, then increased by 6.34% to $126.1 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's Total Non-Current Liabilities are $126.1 million (Q4 2025), $141.1 million (Q3 2025), and $124.3 million (Q2 2025).